IBDEI0JL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9102,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,9102,1,4,0)
 ;;=4^H34.812
 ;;^UTILITY(U,$J,358.3,9102,2)
 ;;=^5005569
 ;;^UTILITY(U,$J,358.3,9103,0)
 ;;=H34.811^^41^474^15
 ;;^UTILITY(U,$J,358.3,9103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9103,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,9103,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,9103,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,9104,0)
 ;;=E11.321^^41^474^66
 ;;^UTILITY(U,$J,358.3,9104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9104,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9104,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,9104,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,9105,0)
 ;;=E11.329^^41^474^67
 ;;^UTILITY(U,$J,358.3,9105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9105,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9105,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,9105,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,9106,0)
 ;;=E11.331^^41^474^68
 ;;^UTILITY(U,$J,358.3,9106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9106,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9106,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,9106,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,9107,0)
 ;;=E11.339^^41^474^69
 ;;^UTILITY(U,$J,358.3,9107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9107,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9107,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,9107,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,9108,0)
 ;;=E11.351^^41^474^70
 ;;^UTILITY(U,$J,358.3,9108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9108,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9108,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,9108,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,9109,0)
 ;;=E11.359^^41^474^71
 ;;^UTILITY(U,$J,358.3,9109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9109,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9109,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,9109,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,9110,0)
 ;;=E11.341^^41^474^72
 ;;^UTILITY(U,$J,358.3,9110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9110,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9110,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,9110,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,9111,0)
 ;;=E11.349^^41^474^73
 ;;^UTILITY(U,$J,358.3,9111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9111,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9111,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,9111,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,9112,0)
 ;;=E11.9^^41^474^74
 ;;^UTILITY(U,$J,358.3,9112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9112,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,9112,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,9112,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,9113,0)
 ;;=H35.363^^41^474^18
 ;;^UTILITY(U,$J,358.3,9113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9113,1,3,0)
 ;;=3^Drusen of Macular,Bilateral
 ;;^UTILITY(U,$J,358.3,9113,1,4,0)
 ;;=4^H35.363
 ;;^UTILITY(U,$J,358.3,9113,2)
 ;;=^5005660
 ;;^UTILITY(U,$J,358.3,9114,0)
 ;;=H35.362^^41^474^19
 ;;^UTILITY(U,$J,358.3,9114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9114,1,3,0)
 ;;=3^Drusen of Macular,Left Eye
 ;;^UTILITY(U,$J,358.3,9114,1,4,0)
 ;;=4^H35.362
